You are here

News

A $12 million award from the Stand Up to Cancer Foundation will help fund trials testing Vitamin C as a therapy for patients with colon, lung and pancreatic cancers.

Read full story

Diabetes drug phenformin shows promise as a treatment for melanoma, according to research from Lewis Cantley, Ph.D., and Jonathan Zippin, M.D., Ph.D.

Read full story

Dr. Cantley was recently elected as Chairman of the Board of Trustees of the Hope Funds for Cancer Research, a charity dedicated to advancing innovative research for the most difficult-to-treat cancers.

Read full story

Dr. Cantley will receive $4.2 million over 7 years to continue his research into PI3K and cancer metabolism.

Read full story

Lewis C. Cantley, Ph.D., and Kristy Richards, Ph.D., M.D. are collaborating to revamp the ways cancer drugs can be researched, tested and approved.

Read full story

Dr. Cantley was among seven selected for the third round of the Daedalus Fund for Innovation awards. 

Read full story

The metabolic state of patients influences their cancer risk, progression and response to treatment.

Read the full story

A new study echoes the findings of the Cantley Lab regarding the potential of Vitamin C as a cancer-killing therapy. 

Read the full story

Cornell University and Weill Cornell will establish a new multi-institutional translational research Center on the Physics of Cancer Metabolism, thanks to a $9.3m National Cancer Institute grant

Read the full story

Dr. Cantley and former postdoc Costas Lyssiotis were involved in a study about pancreatic cancer metabolism.

Read the full story

Dr. Cantley discusses life in and out of the lab.

Read the full story

Dr. Cantley shares some of his advice for those facing cancer, or looking to prevent it. 

Read the full story

Cantley Lab members have found that the gene PIP4K2C and its associated protein PI5P4Kγ play a role in the regulation of the immune system, with potential implications for cancer immunotherapy treatments. 

Read the full story

Karen Vousden, director of the Cancer Research UK Beatson Institute in Glasgow, Scotland, recently spent a month in the Cantley Lab as part of the Vallee Visiting Professorship program.

Read the full story

Dr. Cantley has been recognized by OncLive as a finalist for the 'Giants of Cancer Care' award. 

Read the full story

Dr. Cantley talks to the New York Times Magazine about the "rather scary" influence of sugar on cancer.

Read the full story

Dr. Cantley is one of four recipients of a Hope Funds 2016 Award of Excellence. 

Read the full story

Matthew G. Vander Heiden, M.D., Ph.D., a former postdoc in the Cantley Lab, was honored with a Stand Up to Cancer award.

Read the full story

"People Behind the Science" episode - Dr. Lewis Cantley: A Pathway to Success: Studying Signal Transduction in Cancer and Other Diseases

Listen to the full episode

Dr. Cantley discusses the biotech industry in New York City.

Read the full article

Additional coverage of the identification of PHGDH as a potential target for lung, breast and skin cancers.

Read the full story

Profile of Cantley Lab manager Monica Rosen.

See the full profile

Lab members have identified a small molecule inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH), to target serine biosynthesis in cancers.

See paper here

A collaboration between the Cantley lab and researchers at Beth Israel Deaconess Medical Center has identified a link between a cancer cell's form and shape and its metabolic capabilities.

Read the full article

Lewis Cantley has been awarded "Israel's Nobel Prize."

Read the full story

Lewis Cantley, Ph.D., is heading a new pharmaceutical venture. 

Read the full article

High levels of vitamin C kill certain kinds of colorectal cancers in cell cultures and mice, according to a new study from the Cantley Lab. The findings suggest that scientists could one day harness vitamin C to develop targeted treatments.

Read full story

The Association of American Cancer Institutes (AACI) presented the AACI Distinguished Scientist Award to Lewis Cantley, Ph.D., on October 26, during the 2015 AACI/CCAF Annual Meeting, in Washington, DC. 

Read the full story

In a study published online Oct. 19 in the journal Nature Genetics, Gina DeNicola, Ph.D., and other members of the Cantley Lab elucidated the role of Nrf2 in serine production in non-small cell lung cancer.

Read the full story

Postdoc Costas Lyssiotis is one of six recipients of The Tri-Institutional Breakout Awards for Junior Investigators, which was established in part by Dr. Cantley after he won the 2013 Breakthrough Prize in Life Sciences. 

Read the full story

The Ross Prize, which includes a $50,000 gift, was formally presented to Dr. Cantley at the New York Academy of Sciences in Manhattan, followed by an academic lecture by Dr. Cantley and other preeminent researchers

Read the announcement

Dr. Cantley leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.

Read the full story

Dr. Cantley has been elected to the prestigious European life sciences academy EMBO

Read the full story

Dr. Cantley has been named the recipient of the 3rd annual Ross Prize in Molecular Medicine.

Read the full story

The American Association for Cancer Research (AACR) will honor Dr. Cantley with the ninth annual Princess Takamatsu Memorial Lectureship at its annual meeting.

Read the full story

Dr. Cantley wins prestigious prize: the 2015 Canada Gairdner International Award

Read the full story

Dr. Cantley speaks to Cancer Therapy Advisor about progress in developing and testing effective PI3K pathway inhibitors.

Read the full article

Dr. Cantley pens a guest piece for MediaPlanet about progress in women's cancers.

Read the full article

Postdoc Costas Lyssiotis is featured on Cancer Research Catalyst blog of the American Association for Cancer Research.

Read source article

Dr. Cantley has been elected to the Institute of Medicine of the National Academies, one of the highest honors in the fields of health and medicine.

Read the announcement

The Cornell Alumni Magazine profiles Dr. Lewis Cantley. 

Read the complete profile

Breakthrough Prize winner Lewis Cantley has committed a portion of his award to establish a new annual prize for promising postdoctoral trainees.

Read the full story

Work from the Cantley lab is feaured in this blog post by Weill Cornell Dean Laurie Glimcher.

Read the full story

The Cantley lab is awarded research funds and postdoc Gina DeNicola is named as recipient of the 2014 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant

Read the full story

Postdoc Costas Lyssiotis is named as one of three early career researchers to receive a prestigious award from the Damon Runyon Cancer Research Foundation.

Read the full story

A multi-institutional research team, led by Dr. Lewis Cantley and investigators at Weill Cornell Medical College, has identified a family of enzymes they say is crucial for the growth of cancers that have genetic aberrations in p53.

Read the full story

Dr. Cantley is highlighted in a TIME magazine feature. 

Read the full story

Dr. Lewis Cantley was named a winner of the inaugural Breakthrough Prize in Life Sciences, the world's richest academic prize for medicine and biology.

Read the full story

Weill Cornell Dean Laurie Glimcher sits down with Dr. Cantley to discuss his recruitment to the college.

Read the interview

Dr. Lewis Cantley, a leading cancer researcher, credited with discovering a family of enzymes fundamental to understanding cancer, has been named director of the newly established Cancer Center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

Read the full announcement

Contact Us

Meyer Cancer Center
Belfer Research Building
413 E 69th St.
Room 1362, Box 50
New York, NY 10021
Phone: (646) 962-6297